Cartesian Therapeutics(RNAC) - 2022 Q2 - Earnings Call Transcript

Selecta Biosciences, Inc. (SELB) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Kevin Tan – Chief Financial Officer Carsten Brunn – President and Chief Executive Officer Peter Traber – Chief Medical Officer Kei Kishimoto – Chief Scientific Officer Conference Call Participants Kristen Kluska – Cantor Fitzgerald Yun Zhong – BTIG Yatin Suneja – Guggenheim Partners John Newman – Canaccord Raju Prasad – William Blair Boobalan Pachaiyappan – H.C. Wainwright Operator Good day, and ...